PD-1 as a potential target in cancer therapy

Cancer Medicine

Volumn 2, Issue 5, 2013, Pages 662-673

  Mcdermott, David F ^a,b   Atkins, Michael B ^c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; IMMUNE TOLERANCE; IMMUNOTHERAPY; NIVOLUMAB; PROGRAMMED CELL DEATH-1 RECEPTOR; PROGRAMMED CELL DEATH-1-LIGAND 1;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD274; ANTINEOPLASTIC AGENTS; HUMANS; IMMUNE TOLERANCE; IMMUNOTHERAPY; MOLECULAR TARGETED THERAPY; NEOPLASM PROTEINS; NEOPLASMS; PROGRAMMED CELL DEATH 1 RECEPTOR;

EID: 84893489025     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.106     Document Type: Review

References (66)